{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:22:43Z","timestamp":1790400163276,"version":"4.1.0"},"reference-count":34,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.3892\/or.2017.5533","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T08:47:16Z","timestamp":1490604436000},"page":"3137-3145","source":"Crossref","is-referenced-by-count":53,"title":["Induction of galectin-1 by TLR-dependent PI3K activation enhances epithelial-mesenchymal transition of metastatic ovarian cancer cells"],"prefix":"10.3892","volume":"37","author":[{"given":"Ga Bin","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Hee","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daejin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,3,27]]},"reference":[{"key":"key20180107224616_b1-or-37-05-3137","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20180107224616_b2-or-37-05-3137","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/jb\/mvr044","article-title":"Cancer early dissemination: Cancerous epithelial-mesenchymal transdifferentiation and transforming growth factor \u03b2 signalling","volume":"149","author":"Sabe","year":"2011","journal-title":"J Biochem"},{"key":"key20180107224616_b3-or-37-05-3137","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking ovarian cancer: Recommendations for improving outcomes","volume":"11","author":"Vaughan","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"key20180107224616_b4-or-37-05-3137","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","article-title":"Toll-like receptors: Critical proteins linking innate and acquired immunity","volume":"2","author":"Akira","year":"2001","journal-title":"Nat Immunol"},{"key":"key20180107224616_b5-or-37-05-3137","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12307-009-0022-y","article-title":"Cancer cells expressing toll-like receptors and the tumor microenvironment","volume":"2","author":"Sato","year":"2009","journal-title":"Cancer Microenviron"},{"key":"key20180107224616_b6-or-37-05-3137","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1158\/1078-0432.CCR-07-4467","article-title":"Helicobacter pylori augments growth of gastric cancers via the lipopolysaccharide-toll-like receptor 4 pathway whereas its lipopolysaccharide attenuates antitumor activities of human mononuclear cells","volume":"14","author":"Chochi","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107224616_b7-or-37-05-3137","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1053\/j.gastro.2007.09.008","article-title":"Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors","volume":"133","author":"Fukata","year":"2007","journal-title":"Gastroenterology"},{"key":"key20180107224616_b8-or-37-05-3137","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00262-008-0650-y","article-title":"Toll-like receptor expression in normal ovary and ovarian tumors","volume":"58","author":"Zhou","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"key20180107224616_b9-or-37-05-3137","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ijc.23049","article-title":"Phosphoinositide 3-kinase\/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death","volume":"122","author":"Yu","year":"2008","journal-title":"Int J Cancer"},{"key":"key20180107224616_b10-or-37-05-3137","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"key20180107224616_b11-or-37-05-3137","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1158\/0008-5472.CAN-10-2833","article-title":"LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasis","volume":"71","author":"Hsu","year":"2011","journal-title":"Cancer Res"},{"key":"key20180107224616_b12-or-37-05-3137","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/5042","article-title":"PIK3CA is implicated as an oncogene in ovarian cancer","volume":"21","author":"Shayesteh","year":"1999","journal-title":"Nat Genet"},{"key":"key20180107224616_b13-or-37-05-3137","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0165-4608(01)00567-2","article-title":"Recurrent chromosome alterations in primary ovarian carcinoma in Chinese women","volume":"133","author":"Sham","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"key20180107224616_b14-or-37-05-3137","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10495-013-0807-9","article-title":"Targeted inhibition of phosphatidyl inositol-3-kinase p110\u03b2, but not p110\u03b1, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers","volume":"18","author":"Jeong","year":"2013","journal-title":"Apoptosis"},{"key":"key20180107224616_b15-or-37-05-3137","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2009.09.017","article-title":"Epithelial-mesenchymal transition in ovarian cancer","volume":"291","author":"Vergara","year":"2010","journal-title":"Cancer Lett"},{"key":"key20180107224616_b16-or-37-05-3137","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1084\/jem.179.5.1725","article-title":"Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling","volume":"179","author":"Kurosaki","year":"1994","journal-title":"J Exp Med"},{"key":"key20180107224616_b17-or-37-05-3137","doi-asserted-by":"crossref","first-page":"32662","DOI":"10.1074\/jbc.274.46.32662","article-title":"SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling","volume":"274","author":"Beitz","year":"1999","journal-title":"J Biol Chem"},{"key":"key20180107224616_b18-or-37-05-3137","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/00313020701329914","article-title":"The role of epithelial-mesenchymal transition in cancer pathology","volume":"39","author":"Guarino","year":"2007","journal-title":"Pathology"},{"key":"key20180107224616_b19-or-37-05-3137","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.ejca.2012.02.005","article-title":"High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion","volume":"48","author":"Kim","year":"2012","journal-title":"Eur J Cancer"},{"key":"key20180107224616_b20-or-37-05-3137","doi-asserted-by":"crossref","first-page":"7329","DOI":"10.1158\/0008-5472.CAN-09-0835","article-title":"In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells","volume":"69","author":"Scarlett","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107224616_b21-or-37-05-3137","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1084\/jem.20111413","article-title":"Ovarian cancer progression is controlled by phenotypic changes in dendritic cells","volume":"209","author":"Scarlett","year":"2012","journal-title":"J Exp Med"},{"key":"key20180107224616_b22-or-37-05-3137","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.canlet.2014.12.019","article-title":"Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma","volume":"358","author":"Liu","year":"2015","journal-title":"Cancer Lett"},{"key":"key20180107224616_b23-or-37-05-3137","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.molimm.2007.01.022","article-title":"TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance","volume":"44","author":"He","year":"2007","journal-title":"Mol Immunol"},{"key":"key20180107224616_b24-or-37-05-3137","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1158\/0008-5472.CAN-05-3948","article-title":"TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer","volume":"66","author":"Kelly","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107224616_b25-or-37-05-3137","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N Engl J Med"},{"key":"key20180107224616_b26-or-37-05-3137","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/1521-4141(200108)31:8<2448::AID-IMMU2448>3.0.CO;2-N","article-title":"The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol","volume":"31","author":"Byrd-Leifer","year":"2001","journal-title":"Eur J Immunol"},{"key":"key20180107224616_b27-or-37-05-3137","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1038\/onc.2009.289","article-title":"TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer","volume":"28","author":"Szajnik","year":"2009","journal-title":"Oncogene"},{"key":"key20180107224616_b28-or-37-05-3137","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1189\/jlb.1208763","article-title":"TLR4\/MyD88\/PI3K interactions regulate TLR4 signaling","volume":"85","author":"Laird","year":"2009","journal-title":"J Leukoc Biol"},{"key":"key20180107224616_b29-or-37-05-3137","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1073\/pnas.0408864102","article-title":"Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic","volume":"102","author":"Kang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107224616_b30-or-37-05-3137","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1046\/j.1365-2362.2003.01116.x","article-title":"Time to progression is dependent on the expression of the tumour suppressor PTEN in ovarian cancer patients","volume":"33","author":"Sch\u00f6ndorf","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"key20180107224616_b31-or-37-05-3137","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1309\/BL7EMW66LQX6GFRP","article-title":"Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas","volume":"124","author":"Wang","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"key20180107224616_b32-or-37-05-3137","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ijc.23963","article-title":"Autocrine VEGF-A\/KDR loop protects epithelial ovarian carcinoma cells from anoikis","volume":"124","author":"Sher","year":"2009","journal-title":"Int J Cancer"},{"key":"key20180107224616_b33-or-37-05-3137","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2010.10.027","article-title":"Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells","volume":"301","author":"Satelli","year":"2011","journal-title":"Cancer Lett"},{"key":"key20180107224616_b34-or-37-05-3137","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10585-012-9471-7","article-title":"Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CD8(+) T cells and reduced cancer cell adherence","volume":"29","author":"Ito","year":"2012","journal-title":"Clin Exp Metastasis"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2017.5533\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T17:59:11Z","timestamp":1515347951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2017.5533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,27]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,3,27]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.3892\/or.2017.5533"],"URL":"https:\/\/doi.org\/10.3892\/or.2017.5533","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,27]]}}}